Literature DB >> 29669735

CTGF/VEGFA-activated Fibroblasts Promote Tumor Migration Through Micro-environmental Modulation.

Wei Wu1,2, Esther A Zaal1, Celia R Berkers1, Simone Lemeer1,2, Albert J R Heck3,2.   

Abstract

Fibroblast activation is associated with tumor progression and implicated in metastasis, but the initial triggering signals required to kick-start this process remain largely unknown. Because small cancerous lesions share limited physical contact with neighboring fibroblasts, we reasoned the first tumor-derived signal for fibroblast activation should be secreted and diffusible. By pulsed metabolic labeling and click-chemistry based affinity enrichment, we sieved through the ductal carcinoma secretome for potential fibroblast activators. Using immuno-depletion/supplementation assays on various secreted factors, we pinpointed that tumor-secreted CTGF/VEGFA alone is sufficient to activate paired mammary fibroblasts from the same patient via ROCK1 and JunB signaling. Fibroblasts activated in this manner are distinct in morphology, growth, and adopt a highly tumor-like secretion profile, which in turn promotes tumor migration by counteracting oxidative and lactate stress. These findings reveal a profound division-of-labor between normal and cancer cells under the directive of the latter, and allude to potential metastatic prevention through inhibiting local fibroblast activation.
© 2018 Wu et al.

Entities:  

Keywords:  Click chemistry; Mass Spectrometry; Metastasis; Secretome; Tumor microenvironment; fibroblast activation; reciprocal signaling

Mesh:

Substances:

Year:  2018        PMID: 29669735      PMCID: PMC6072540          DOI: 10.1074/mcp.RA118.000708

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  51 in total

Review 1.  Extracellular matrix determinants of proteolytic and non-proteolytic cell migration.

Authors:  Katarina Wolf; Peter Friedl
Journal:  Trends Cell Biol       Date:  2011-10-27       Impact factor: 20.808

2.  Cancer: Fibroblasts for all seasons.

Authors:  Erwin F Wagner
Journal:  Nature       Date:  2016-02-04       Impact factor: 49.962

Review 3.  Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors.

Authors:  Judith Campisi
Journal:  Cell       Date:  2005-02-25       Impact factor: 41.582

Review 4.  Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential.

Authors:  Padmanee Sharma; James P Allison
Journal:  Cell       Date:  2015-04-09       Impact factor: 41.582

Review 5.  The biology and function of fibroblasts in cancer.

Authors:  Raghu Kalluri
Journal:  Nat Rev Cancer       Date:  2016-08-23       Impact factor: 60.716

Review 6.  Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression.

Authors:  Cassandra L Buchheit; Kelsey J Weigel; Zachary T Schafer
Journal:  Nat Rev Cancer       Date:  2014-08-07       Impact factor: 60.716

7.  Downregulation of miR-30c promotes renal fibrosis by target CTGF in diabetic nephropathy.

Authors:  Jinyang Wang; Lijun Duan; Tiankang Guo; Yanbin Gao; Limin Tian; Jing Liu; Shaocheng Wang; Jinkui Yang
Journal:  J Diabetes Complications       Date:  2015-12-17       Impact factor: 2.852

Review 8.  The senescence-associated secretory phenotype: the dark side of tumor suppression.

Authors:  Jean-Philippe Coppé; Pierre-Yves Desprez; Ana Krtolica; Judith Campisi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

9.  Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells.

Authors:  Craig A Cooney; Fariba Jousheghany; Aiwei Yao-Borengasser; Bounleut Phanavanh; Tina Gomes; Ann Marie Kieber-Emmons; Eric R Siegel; Larry J Suva; Soldano Ferrone; Thomas Kieber-Emmons; Behjatolah Monzavi-Karbassi
Journal:  Breast Cancer Res       Date:  2011-06-09       Impact factor: 6.466

10.  Therapy-induced tumour secretomes promote resistance and tumour progression.

Authors:  Anna C Obenauf; Yilong Zou; Andrew L Ji; Sakari Vanharanta; Weiping Shu; Hubing Shi; Xiangju Kong; Marcus C Bosenberg; Thomas Wiesner; Neal Rosen; Roger S Lo; Joan Massagué
Journal:  Nature       Date:  2015-03-25       Impact factor: 49.962

View more
  5 in total

Review 1.  Regulation of breast cancer metastasis signaling by miRNAs.

Authors:  Belinda J Petri; Carolyn M Klinge
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

Review 2.  Non-canonical roles for metabolic enzymes and intermediates in malignant progression and metastasis.

Authors:  Demond Williams; Barbara Fingleton
Journal:  Clin Exp Metastasis       Date:  2019-05-09       Impact factor: 5.150

3.  Single-Cell Profiling of AKI in a Murine Model Reveals Novel Transcriptional Signatures, Profibrotic Phenotype, and Epithelial-to-Stromal Crosstalk.

Authors:  Valeria Rudman-Melnick; Mike Adam; Andrew Potter; Saagar M Chokshi; Qing Ma; Keri A Drake; Meredith P Schuh; J Matthew Kofron; Prasad Devarajan; S Steven Potter
Journal:  J Am Soc Nephrol       Date:  2020-10-28       Impact factor: 10.121

4.  PDGF-BB regulates the transformation of fibroblasts into cancer-associated fibroblasts via the lncRNA LURAP1L-AS1/LURAP1L/IKK/IκB/NF-κB signaling pathway.

Authors:  Xiaobin Ren; Lei Li; Jianhua Wu; Ken Lin; Yongwen He; Li Bian
Journal:  Oncol Lett       Date:  2021-05-19       Impact factor: 2.967

5.  Correlation between ELF-PEMF exposure and Human RPE Cell Proliferation, Apoptosis and Gene Expression.

Authors:  Morteza Oladnabi; Mohammad Amir Mishan; Mozhgan Rezaeikanavi; Mehryar Zargari; Rouhallah Najjar Sadeghi; Abouzar Bagheri
Journal:  J Ophthalmic Vis Res       Date:  2021-04-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.